Nacon SA (NACON) ニュース

Draino thinks Massie is a never Trumper. I always thought he was super fiscally conservative. We will see.

Good job Massie

Per the usual, you engaged in a lot of self-serving theatrics, nobody agreed with you, and you changed nothing
https://x.com/DC_Draino/statu

Gonna assume you mean for our drug. In the small phase 2a, there was. For the 2b/3, there is a chart only relatively recently provided by the company that shows potential positive ADL trend for dosed vs placebo, though not stat-sig.

You'll have to define "improvement". Note that any c

The drug effect you're trying to prove in the context of this thread is the abandoned and immaterial ADL endpoint, which would clearly benefit from more time in a trial. However, there is no point to that endpoint, whose time is at an end, if you get my point.

$ILLR Triller is a great way to profit from the demise of TikTok in the US!

https://investorshub.advfn.com/uimage/uploads/2024/12/1/wqnywtik-cban-coming.gif

So if the EMA approves the MAA is the study still insufficient?

QQQ (Invesco QQQ Trust) Weekly Analysis
By: TrendSpider | January 3, 2025

• The QQQ ETF delivered the highest percentage returns in 2024, climbing $109.78 per share to close the year at $511.23 (+27.05%). Unlike the SPY, which struggled in Q4, the tech-heavy index regained

Triller is a great way to profit from the demise of TikTok in the US!
$ILLR

https://investorshub.advfn.com/uimage/uploads/2024/12/1/wqnywtik-cban-coming.gif

And no dilution since Melvin retired shares!!! Brilliant 

Part 1of 4. Another week passes 01/03/2025.
Another week and another year passes and LQMT’s share price is 3.45% from 0.042 cents to 0.04055 cents for the week and down 33% for the year 2024, on extremely weak trading volumes and little interest. The same when LQMT moves up or down. And anoth

An AVXL investment at $13.30 offers an extremely favorable risk/reward ratio given the current odds of EMA approval between 60% and 90% according to ChatGPT.
As may be recalled, Biogen, upon the disputed approval for their Alzheimer's drug, gained $16 Billion or about 40% in price.
A

Speaker Johnson was just re-elected for a 2nd term with the gavel

Was he MAGA’s top choice? Not even close

Is he better than McCarthy? Yes

Can he be pressured towards the MAGA agenda? Absolutely

We now have Trump in the White House, Elon on

SPY (SPDR S&P 500) Weekly Analysis
By: TrendSpider | January 3, 2025

• The SPY ETF emerged as the top dollar gainer in 2024, adding an impressive $113.41 per share to close the year at $586.02 (+23.99%). However, Q4 delivered the most modest gains of the year, with the ind

Haha, working you two like a puppet, I gotta go wash up, finger tips to the elbow. Enjoy your Saturday, gotta catch a flight. But you made my wait at the gate so much fun today.

They have cut their deals. Did your comprehend the last PR?
The last PR was a deal where York agreed to sell the shares into the market for them. It is exactly what they have been doing for years, but now they paid somebody to run it for them.

They will still be limited by the

What irks me is the $40 market order sell at 3:07 dropping the PPS -26%.

Wow - This story keeps getting crazier

Did the Vegas Green Beret commit suicide in a public way to draw attention to his disclosure of government technology secrets?
https://x.com/DC_Draino/status/1875325303465361817

💹per SEC💹Rules $95 Possible, Correct Grandma?💹 @Idiot Mayor Updates the SEC Daily

"insider? I barely know her bro... believe it"
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif

Ummm. The alternative to your line of concern of "an otherwise insufficient study in totally" is to run another study. I think the word you were looking for is "totality", but I understand your meaning.

So your risk is "the risk that one or more studies will be required".

Please stay on topic folks...RDAR/Telvantis ✌️ 

This board is full of paid pumpers. My ignore list is stocked with these clowns. Reading their post is like watching all the billionaires who kneel at the bloated foot of the next (non) president. Groveling is never a good look.

Is mar a largo open to the public?